Mondrian Investment Partners LTD Novartis Ag Transaction History
Mondrian Investment Partners LTD
- $5.77 Billion
- Q2 2024
A detailed history of Mondrian Investment Partners LTD transactions in Novartis Ag stock. As of the latest transaction made, Mondrian Investment Partners LTD holds 1,272,482 shares of NVS stock, worth $148 Million. This represents 2.35% of its overall portfolio holdings.
Number of Shares
1,272,482
Previous 2,065,739
38.4%
Holding current value
$148 Million
Previous $200 Million
32.2%
% of portfolio
2.35%
Previous 2.94%
Shares
19 transactions
Others Institutions Holding NVS
# of Institutions
1,426Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.42 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.41 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$860 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$859 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$690 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...